Immunohistochemistry in ocular carcinomas.
Brett Sramek1, Allison Lisle, Timothy Loy
1Department of Pathology and Anatomical Sciences, University of Missouri, Columbia, MO 65212, USA. sramekb@health.missouri.edu
Differentiating ocular sebaceous carcinoma, squamous cell carcinoma, and basal cell carcinoma can be difficult. An immunohistochemical panel using epithelial membrane antigen (EMA) and Ber-EP4 aids in accurate diagnosis of these challenging ocular tumors.
Area of Science:
- Ophthalmology
- Dermatopathology
- Oncology
Background:
- Distinguishing between ocular sebaceous carcinoma, poorly differentiated ocular squamous cell carcinoma, and ocular basal cell carcinoma presents diagnostic challenges.
- Immunohistochemistry offers a potential solution for differentiating these complex ocular lesions.
Purpose of the Study:
- To evaluate the utility of an immunohistochemical panel in differentiating ocular sebaceous carcinoma, squamous cell carcinoma, and basal cell carcinoma.
- To determine the expression patterns of specific immunostains in these distinct tumor types.
Main Methods:
- Formalin-fixed, paraffin-embedded tissue samples of each tumor type were analyzed.
- Immunohistochemical techniques were employed to assess the distribution of various immunostains.
Main Results:
- Cytokeratin (CK)7 positivity was observed in 100% of sebaceous carcinomas.
- Epithelial membrane antigen (EMA) was positive in 100% of squamous cell carcinomas and 80% of sebaceous carcinomas, but negative in basal cell carcinomas.
- Ber-EP4 was positive in 100% of basal cell carcinomas and 80% of sebaceous carcinomas, while negative in all squamous cell carcinomas.
Conclusions:
- An EMA positive, Ber-EP4 positive immunophenotype supports sebaceous carcinoma.
- An EMA positive, Ber-EP4 negative result indicates squamous cell carcinoma.
- An EMA negative, Ber-EP4 positive result suggests basal cell carcinoma.
More Related Videos
05:15Isolation of Intact Eyeball to Obtain Integral Ocular Surface Tissue for Histological Examination and Immunohistochemistry
Published on: October 20, 2019
10:35An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses
Published on: November 28, 2010
